Microbot Medical Inc.
MBOT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883975
No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Microbot Medical Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Microbot Medical Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Burell Scott R | Director | – | Apr 3, 2026 | 1 |
| Madden Martin J. | Director | – | Apr 3, 2026 | 1 |
| Laxminarain Prattipati | Director | – | Apr 3, 2026 | 1 |
| Stockburger Aileen Ptucha | Director | – | Apr 3, 2026 | 1 |
| Wenderow Tal Baruch | Director | – | Apr 3, 2026 | 1 |
| Wilson David James | Director | – | Apr 3, 2026 | 1 |
| Gadot Harel | Chairman, President and CEO | – | Feb 20, 2026 | 1 |
| Sharon Simon | General Manager, CTO | – | Feb 20, 2026 | 1 |
| Vaknin Rachel | Chief Financial Officer | – | Feb 20, 2026 | 1 |
| Diaz-Cartelle Juan | Chief Medical Officer | – | Feb 20, 2026 | 1 |
| Bornstein Yoseph | Director | – | Nov 6, 2023 | 0 |
| Morag Eyal | Chief Medical Officer | – | Aug 3, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.